{"id":"W4408562453","doi":"10.1016/j.esmoop.2025.104497","title":"Effect of palbociclib plus letrozole on patient-reported health-related quality of life: extended follow-up of the PALOMA-2 trial","year":2025,"lang":"en","type":"article","venue":"ESMO Open","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"AstraZeneca; Les Laboratories Pierre Fabre; Seagen; Gilead Sciences; Pfizer; Daiichi Sankyo Europe; Eli Lilly and Company","keywords":"Palbociclib; Letrozole; Medicine; Gynecology; Internal medicine; Cancer; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001382576,0.0001976004,0.001286988,0.0000923254,0.00006792599,0.000005691078,0.0003776507,0.0001132044,0.0001290302],"category_scores_gemma":[0.001292114,0.000129504,0.000282524,0.0005304447,0.0001970765,0.00006799877,0.000217336,0.0002476645,0.000002026898],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000149929,"about_ca_system_score_gemma":0.0007553517,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004503536,"about_ca_topic_score_gemma":0.0001631013,"domain_scores_codex":[0.9968249,0.0007847692,0.001396091,0.0003024139,0.0004643228,0.0002274587],"domain_scores_gemma":[0.9969903,0.0005353067,0.001310728,0.00092223,0.0001579061,0.00008350274],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7214604,0.001486205,0.03918486,0.002119332,0.003079347,0.00001128586,0.003510059,0.000167178,0.009352431,0.003138202,0.001810518,0.2146802],"study_design_scores_gemma":[0.4124282,0.01253181,0.3802748,0.002818799,0.0004585731,0.000007424655,0.0005975538,0.00005245145,0.1863382,0.001480412,0.002657176,0.0003545658],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912674,0.0003980524,0.00003578091,0.001296838,0.0008346424,0.003388844,0.00003284392,0.00002394725,0.002721609],"genre_scores_gemma":[0.998422,0.00001025448,0.00008571924,0.0004061126,0.00002398159,0.00009675949,0.0000227288,0.00002105583,0.000911367],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.34109,"threshold_uncertainty_score":0.6808029,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03697220638522724,"score_gpt":0.3806589555226792,"score_spread":0.343686749137452,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}